| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | RIPK1 CDK15 OBSCN DAPK1 RIPK4 MAP3K6 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 8.10e-06 | 363 | 161 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | RIPK1 GNE CDK15 FN3KRP OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 PIK3CD MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 1.74e-05 | 709 | 161 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | RIPK1 GNE CDK15 FN3KRP OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 PIK3CD MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 4.63e-05 | 764 | 161 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RIPK1 CDK15 OBSCN DAPK1 RIPK4 MAP3K6 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 6.91e-05 | 446 | 161 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | RIPK1 CDK15 OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 1.07e-04 | 600 | 161 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX16 MYO1G DYNC2H1 ATP13A1 SMC1A UBA2 RNF213 DHX33 KIF20B DHX8 DNAH1 DDX50 TOR1B ABCC2 DNAH9 | 1.38e-04 | 614 | 161 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | dihydrofolic acid binding | 1.93e-04 | 3 | 161 | 2 | GO:0051871 | |
| GeneOntologyMolecularFunction | dihydrofolate reductase activity | 1.93e-04 | 3 | 161 | 2 | GO:0004146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RIPK1 GNE CDK15 FN3KRP OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 PAPOLA PIK3CD MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 2.06e-04 | 938 | 161 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX16 DYNC2H1 ATP13A1 SMC1A RNF213 DHX33 KIF20B DHX8 DDX50 TOR1B ABCC2 DNAH9 | 2.49e-04 | 441 | 161 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.84e-04 | 18 | 161 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 4.68e-04 | 122 | 161 | 6 | GO:0072341 | |
| GeneOntologyMolecularFunction | folic acid binding | 5.30e-04 | 20 | 161 | 3 | GO:0005542 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.17e-03 | 26 | 161 | 3 | GO:0070402 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.07e-05 | 177 | 161 | 9 | GO:0030010 | |
| Domain | Kinase-like_dom | RIPK1 CDK15 FN3KRP OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 PTPN13 PIK3CD MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 1.27e-06 | 542 | 163 | 18 | IPR011009 |
| Domain | LRRC37AB_C | 2.59e-06 | 4 | 163 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.59e-06 | 4 | 163 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.59e-06 | 4 | 163 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.59e-06 | 4 | 163 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.59e-06 | 4 | 163 | 3 | IPR015753 | |
| Domain | ANK | DAPK1 RIPK4 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 1.32e-05 | 251 | 163 | 11 | SM00248 |
| Domain | ANK_REPEAT | DAPK1 RIPK4 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 1.42e-05 | 253 | 163 | 11 | PS50088 |
| Domain | ANK_REP_REGION | DAPK1 RIPK4 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 1.47e-05 | 254 | 163 | 11 | PS50297 |
| Domain | Ser/Thr_kinase_AS | RIPK1 CDK15 OBSCN DAPK1 RIPK4 MAP3K6 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 1.56e-05 | 357 | 163 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | RIPK1 CDK15 OBSCN DAPK1 RIPK4 MAP3K6 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 1.81e-05 | 362 | 163 | 13 | PS00108 |
| Domain | Ankyrin_rpt | DAPK1 RIPK4 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 1.96e-05 | 262 | 163 | 11 | IPR002110 |
| Domain | Prot_kinase_dom | RIPK1 CDK15 OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 2.59e-05 | 489 | 163 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | RIPK1 CDK15 OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 2.85e-05 | 493 | 163 | 15 | PS50011 |
| Domain | Pkinase | RIPK1 CDK15 OBSCN PKDCC DAPK1 RIPK4 MAP3K6 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 STK24 | 3.09e-05 | 381 | 163 | 13 | PF00069 |
| Domain | Ank | DAPK1 RIPK4 ASAP1 ANKRD46 ANKRD44 KANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 3.26e-05 | 228 | 163 | 10 | PF00023 |
| Domain | PROTEIN_KINASE_ATP | CDK15 OBSCN PKDCC DAPK1 RIPK4 MAP3K6 PTK2 STK11 MAP4K5 BUB1B RPS6KA6 ULK1 MAP3K21 STK24 | 5.18e-05 | 459 | 163 | 14 | PS00107 |
| Domain | - | DAPK1 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 6.63e-05 | 248 | 163 | 10 | 1.25.40.20 |
| Domain | DHFR_1 | 7.57e-05 | 2 | 163 | 2 | PF00186 | |
| Domain | DHFR_1 | 7.57e-05 | 2 | 163 | 2 | PS00075 | |
| Domain | DHFR_dom | 7.57e-05 | 2 | 163 | 2 | IPR001796 | |
| Domain | DHFR_2 | 7.57e-05 | 2 | 163 | 2 | PS51330 | |
| Domain | - | 7.57e-05 | 2 | 163 | 2 | 3.40.430.10 | |
| Domain | DHFR-like_dom | 7.57e-05 | 2 | 163 | 2 | IPR024072 | |
| Domain | DHFR | 7.57e-05 | 2 | 163 | 2 | IPR012259 | |
| Domain | Ankyrin_rpt-contain_dom | DAPK1 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 8.08e-05 | 254 | 163 | 10 | IPR020683 |
| Domain | Ank_2 | DAPK1 ASAP1 ANKRD46 ANKRD44 KANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 1.16e-04 | 215 | 163 | 9 | PF12796 |
| Domain | ARM-type_fold | DOCK2 USP9X RTTN PSMD2 NBEA CLASP2 PPP6R1 PPP4R4 PIK3CD TERB1 WDFY3 | 1.98e-04 | 339 | 163 | 11 | IPR016024 |
| Domain | Dynein_heavy_chain_D4_dom | 2.21e-04 | 14 | 163 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.21e-04 | 14 | 163 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.21e-04 | 14 | 163 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.21e-04 | 14 | 163 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.21e-04 | 14 | 163 | 3 | IPR011704 | |
| Domain | MT | 2.21e-04 | 14 | 163 | 3 | PF12777 | |
| Domain | AAA_8 | 2.21e-04 | 14 | 163 | 3 | PF12780 | |
| Domain | AAA_5 | 2.21e-04 | 14 | 163 | 3 | PF07728 | |
| Domain | Vps51 | 2.26e-04 | 3 | 163 | 2 | IPR014812 | |
| Domain | DHC_fam | 2.75e-04 | 15 | 163 | 3 | IPR026983 | |
| Domain | CAP | 2.75e-04 | 15 | 163 | 3 | PF00188 | |
| Domain | SCP | 2.75e-04 | 15 | 163 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 2.75e-04 | 15 | 163 | 3 | IPR001283 | |
| Domain | Dynein_heavy | 2.75e-04 | 15 | 163 | 3 | PF03028 | |
| Domain | - | 2.75e-04 | 15 | 163 | 3 | 3.40.33.10 | |
| Domain | Dynein_heavy_dom | 2.75e-04 | 15 | 163 | 3 | IPR004273 | |
| Domain | CAP_domain | 2.75e-04 | 15 | 163 | 3 | IPR014044 | |
| Domain | S_TKc | RIPK1 CDK15 OBSCN DAPK1 MAP3K6 STK11 MAP4K5 RPS6KA6 ULK1 MAP3K21 STK24 | 3.23e-04 | 359 | 163 | 11 | SM00220 |
| Domain | DUF1605 | 4.06e-04 | 17 | 163 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 4.06e-04 | 17 | 163 | 3 | PF07717 | |
| Domain | P-loop_NTPase | DHX16 MYO1G DYNC2H1 SMC1A RNF213 DAPK1 ARL9 DHX33 KIF20B DHX8 DNAH1 EHD2 TRANK1 DDX50 TOR1B ABCC2 DNAH9 RHOT1 | 4.48e-04 | 848 | 163 | 18 | IPR027417 |
| Domain | DUF3338 | 4.49e-04 | 4 | 163 | 2 | PF11819 | |
| Domain | DUF3338 | 4.49e-04 | 4 | 163 | 2 | IPR021774 | |
| Domain | HA2 | 4.84e-04 | 18 | 163 | 3 | SM00847 | |
| Domain | HA2 | 4.84e-04 | 18 | 163 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 4.84e-04 | 18 | 163 | 3 | IPR007502 | |
| Domain | Protein_kinase_ATP_BS | CDK15 OBSCN DAPK1 MAP3K6 PTK2 STK11 MAP4K5 RPS6KA6 ULK1 MAP3K21 STK24 | 5.09e-04 | 379 | 163 | 11 | IPR017441 |
| Domain | ARM-like | 6.23e-04 | 270 | 163 | 9 | IPR011989 | |
| Domain | FERM_M | 6.86e-04 | 46 | 163 | 4 | PF00373 | |
| Domain | FerI | 7.44e-04 | 5 | 163 | 2 | SM01202 | |
| Domain | FerB | 7.44e-04 | 5 | 163 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 7.44e-04 | 5 | 163 | 2 | IPR012561 | |
| Domain | Anaphylatoxin_comp_syst | 7.44e-04 | 5 | 163 | 2 | IPR018081 | |
| Domain | Ferlin_C | 7.44e-04 | 5 | 163 | 2 | PF16165 | |
| Domain | Ferlin_C | 7.44e-04 | 5 | 163 | 2 | IPR032362 | |
| Domain | FerIin_dom | 7.44e-04 | 5 | 163 | 2 | IPR012968 | |
| Domain | Anaphylatoxn_comp_syst_dom | 7.44e-04 | 5 | 163 | 2 | IPR001840 | |
| Domain | FerI | 7.44e-04 | 5 | 163 | 2 | PF08151 | |
| Domain | FerB | 7.44e-04 | 5 | 163 | 2 | PF08150 | |
| Domain | Sterol-sensing | 7.44e-04 | 5 | 163 | 2 | PF12349 | |
| Domain | DUF4704 | 7.44e-04 | 5 | 163 | 2 | IPR031570 | |
| Domain | DUF4704 | 7.44e-04 | 5 | 163 | 2 | PF15787 | |
| Domain | FERM_central | 8.73e-04 | 49 | 163 | 4 | IPR019748 | |
| Domain | FERM_domain | 8.73e-04 | 49 | 163 | 4 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 9.42e-04 | 50 | 163 | 4 | IPR014352 | |
| Domain | FERM_1 | 9.42e-04 | 50 | 163 | 4 | PS00660 | |
| Domain | FERM_2 | 9.42e-04 | 50 | 163 | 4 | PS00661 | |
| Domain | FERM_3 | 9.42e-04 | 50 | 163 | 4 | PS50057 | |
| Domain | Band_41_domain | 9.42e-04 | 50 | 163 | 4 | IPR019749 | |
| Domain | B41 | 9.42e-04 | 50 | 163 | 4 | SM00295 | |
| Domain | PH_BEACH | 1.11e-03 | 6 | 163 | 2 | PF14844 | |
| Domain | PH_dom-like | OBSCN NBEA SSRP1 FRMD4B PTK2 ASAP1 EXOC8 FRMD4A PTPN13 PLCB4 WDFY3 | 1.32e-03 | 426 | 163 | 11 | IPR011993 |
| Domain | FERM_C | 1.46e-03 | 26 | 163 | 3 | PF09380 | |
| Domain | ANATO | 1.54e-03 | 7 | 163 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.54e-03 | 7 | 163 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.54e-03 | 7 | 163 | 2 | PS01177 | |
| Domain | ANATO | 1.54e-03 | 7 | 163 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.54e-03 | 7 | 163 | 2 | IPR000020 | |
| Domain | FERM_PH-like_C | 1.64e-03 | 27 | 163 | 3 | IPR018980 | |
| Domain | FERM_C | 1.64e-03 | 27 | 163 | 3 | SM01196 | |
| Domain | DHC_N1 | 2.05e-03 | 8 | 163 | 2 | PF08385 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.05e-03 | 8 | 163 | 2 | IPR019565 | |
| Domain | PH-BEACH_dom | 2.05e-03 | 8 | 163 | 2 | IPR023362 | |
| Domain | - | 2.05e-03 | 8 | 163 | 2 | 2.30.29.40 | |
| Domain | Thiol-ester_cl | 2.05e-03 | 8 | 163 | 2 | PF10569 | |
| Domain | PH_BEACH | 2.05e-03 | 8 | 163 | 2 | PS51783 | |
| Domain | MacrogloblnA2_CS | 2.05e-03 | 8 | 163 | 2 | IPR019742 | |
| Domain | Dynein_heavy_dom-1 | 2.05e-03 | 8 | 163 | 2 | IPR013594 | |
| Domain | - | DHX16 DYNC2H1 SMC1A RNF213 ARL9 DHX33 DHX8 DNAH1 EHD2 TRANK1 DDX50 TOR1B ABCC2 DNAH9 RHOT1 | 2.29e-03 | 746 | 163 | 15 | 3.40.50.300 |
| Domain | BEACH | 2.62e-03 | 9 | 163 | 2 | PS50197 | |
| Domain | Beach | 2.62e-03 | 9 | 163 | 2 | PF02138 | |
| Domain | - | 2.62e-03 | 9 | 163 | 2 | 1.10.1540.10 | |
| Pubmed | DOCK2 RIPK1 SYNE1 OBSCN RNF213 SEZ6L2 LRIG3 FASN RNF123 GLG1 | 1.07e-07 | 214 | 169 | 10 | 22199357 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 1.13e-07 | 3 | 169 | 3 | 26170455 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 1.13e-07 | 3 | 169 | 3 | 33603190 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP9X SMC1A PSMD2 HMGCR COPS3 PPP6R1 SSRP1 DDB1 CUL5 CERS5 FASN EFHD1 DHFR ANKRD52 RHOT1 | 1.47e-07 | 571 | 169 | 15 | 37167062 |
| Pubmed | Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. | 2.58e-07 | 12 | 169 | 4 | 35512830 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 16709836 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 26147384 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 22419166 | ||
| Pubmed | DHX16 PPP6R1 MAP3K6 PTK2 EXOC8 CUL5 BUB1B C4A C4B ULK1 CWF19L1 QSOX2 ALG1 RHOT1 MOCOS | 7.54e-07 | 650 | 169 | 15 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TPRA1 LMF1 VPS13C SPTB OBSCN RNF213 CLASP2 SMOC2 PTK2 PPP4R4 DNAH1 CUL5 ANKRD44 LRPPRC PTPN13 PTPRG GPR137C EFHD1 GCC2 NAXD PLCB4 MOCOS PCNT | 9.96e-07 | 1489 | 169 | 23 | 28611215 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | USP9X OBSCN NBEA CLASP2 COPS3 DYSF DDB1 KRBA1 TRANK1 LGI2 C4A C4B PLCB4 | 1.08e-06 | 497 | 169 | 13 | 36774506 |
| Pubmed | DOCK2 MYO1G ATP13A1 USP9X RNF213 PSMD2 CLASP2 ANO10 LTB4R2 ACOX3 EXOC8 LRPPRC FASN DDX50 GLG1 GCC2 ZW10 ALG1 RHOT1 PCNT | 1.14e-06 | 1168 | 169 | 20 | 19946888 | |
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 1.38e-06 | 162 | 169 | 8 | 14743216 | |
| Pubmed | CDK15 OGFR USP9X FN3KRP UBA2 PSMD2 COPS3 CRMP1 EXOC8 GSTM3 LRPPRC FASN PAPOLA COG1 FH QSOX2 PCMT1 | 1.50e-06 | 878 | 169 | 17 | 37223481 | |
| Pubmed | An integrated genetic map of the pearl locus of mouse chromosome 13. | 1.97e-06 | 19 | 169 | 4 | 8828042 | |
| Pubmed | DHX16 RIPK1 ATP13A1 VPS13C ANO10 SSRP1 GSTM3 PTPN13 COG1 EFHD1 GLG1 MAP4K5 DHFR TTC13 MAP3K21 CWF19L1 QSOX2 PCMT1 | 2.24e-06 | 1007 | 169 | 18 | 34597346 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 DIS3L2 GNE SMC1A PSMD2 COPS3 DHX33 SSRP1 DDB1 KIF20B PTK2 ASAP1 LRPPRC FASN DDX50 BAZ2A MAP4K5 WDFY3 CDC27 ANKRD52 PCMT1 | 2.85e-06 | 1353 | 169 | 21 | 29467282 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CDK15 USP9X SMC1A NELFB MCC UBA2 PSMD2 CLASP2 COPS3 PTK2 CUL5 GSTM3 LRPPRC RNF123 EFHD1 ULK1 ZW10 MAP3K21 STK24 PCMT1 | 4.75e-06 | 1284 | 169 | 20 | 17353931 |
| Pubmed | ATP13A1 USP9X SYNE1 SMC1A SPTB PLA2G3 PSMD2 NBEA RIPK4 FRMD4B PTK2 CRMP1 WDR19 RNF123 PTPN13 OTOF COG1 PPP1R16B WDFY3 PCNT | 4.81e-06 | 1285 | 169 | 20 | 35914814 | |
| Pubmed | DHX16 SYNE1 PPP6R1 ASAP1 LRIG3 KANK1 LGI2 BAZ2A GCC2 ULK1 PCNT | 5.45e-06 | 407 | 169 | 11 | 12693553 | |
| Pubmed | 6.11e-06 | 198 | 169 | 8 | 24337577 | ||
| Pubmed | Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. | 6.20e-06 | 8 | 169 | 3 | 18186651 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GNE OGFR USP9X SMC1A NELFB UBA2 PSMD2 COPS3 SSRP1 DDB1 CRMP1 CUL5 GDA FASN RNF123 PAPOLA ASB6 BUB1B ZW10 FH STK24 | 8.68e-06 | 1455 | 169 | 21 | 22863883 |
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 21187329 | ||
| Pubmed | 1.20e-05 | 156 | 169 | 7 | 22952844 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 23064749 | ||
| Pubmed | Regulation of axonal morphogenesis by the mitochondrial protein Efhd1. | 1.32e-05 | 10 | 169 | 3 | 32414840 | |
| Pubmed | LMF1 ATP13A1 VPS13C SLC43A1 MCC RNF213 CLASP2 HMGCR DDB1 FRMD4B DHX8 KANK1 ASB6 TTC13 | 1.53e-05 | 733 | 169 | 14 | 34672954 | |
| Pubmed | 1.74e-05 | 32 | 169 | 4 | 36278411 | ||
| Pubmed | USP9X SYNE1 SPTB DAPK1 PSMD2 NBEA CLASP2 COPS3 DDB1 ASAP1 CRMP1 CUL5 CERS5 GDA LRPPRC FASN C4A C4B FH RHOT1 | 2.28e-05 | 1431 | 169 | 20 | 37142655 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.35e-05 | 2 | 169 | 2 | 16565498 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15998580 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19062096 | ||
| Pubmed | The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma. | 2.35e-05 | 2 | 169 | 2 | 23906871 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.35e-05 | 2 | 169 | 2 | 19933335 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15121855 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.35e-05 | 2 | 169 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.35e-05 | 2 | 169 | 2 | 17645767 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.35e-05 | 2 | 169 | 2 | 27758680 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.35e-05 | 2 | 169 | 2 | 23749435 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.35e-05 | 2 | 169 | 2 | 3037333 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11726230 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.35e-05 | 2 | 169 | 2 | 6950384 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.35e-05 | 2 | 169 | 2 | 8428773 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.35e-05 | 2 | 169 | 2 | 21345967 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2572548 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2302180 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.35e-05 | 2 | 169 | 2 | 18091514 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29080553 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.35e-05 | 2 | 169 | 2 | 25339671 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17728371 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6149580 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6149581 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12115608 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 3542363 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2387317 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23637231 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16908004 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7365238 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7391573 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17971360 | ||
| Pubmed | The Autophagy-Initiating Kinase ULK1 Controls RIPK1-Mediated Cell Death. | 2.35e-05 | 2 | 169 | 2 | 32320653 | |
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 2.35e-05 | 2 | 169 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.35e-05 | 2 | 169 | 2 | 17971229 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 2.35e-05 | 2 | 169 | 2 | 17921792 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 2.35e-05 | 2 | 169 | 2 | 6978711 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 35898513 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28873507 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 2.35e-05 | 2 | 169 | 2 | 6832377 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 3794341 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22785613 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 2.35e-05 | 2 | 169 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 2.35e-05 | 2 | 169 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 2.35e-05 | 2 | 169 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 2.35e-05 | 2 | 169 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 2.35e-05 | 2 | 169 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 2.35e-05 | 2 | 169 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 2.35e-05 | 2 | 169 | 2 | 15787745 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 30026462 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 2.35e-05 | 2 | 169 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 2.35e-05 | 2 | 169 | 2 | 20506482 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12480675 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26126547 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 2.35e-05 | 2 | 169 | 2 | 15390104 | |
| Interaction | DNAJC7 interactions | DYNC2H1 VPS13C PSMD2 RIPK4 DDB1 KIF20B WDR19 FASN DHFR2 BUB1B MAP3K21 MOCOS RAD9A PCNT | 1.11e-05 | 425 | 165 | 14 | int:DNAJC7 |
| Interaction | HUWE1 interactions | PDE4A USP9X SMC1A SPTB PSMD2 HMGCR COPS3 RIPK4 PPP6R1 SSRP1 DDB1 CRMP1 CUL5 CERS5 FASN RNF123 PAPOLA EFHD1 DHFR DHFR2 ANKRD52 PCMT1 RHOT1 PCNT | 1.26e-05 | 1110 | 165 | 24 | int:HUWE1 |
| Cytoband | 6q24-q25 | 1.34e-04 | 5 | 169 | 2 | 6q24-q25 | |
| GeneFamily | Ankyrin repeat domain containing | DAPK1 RIPK4 ASAP1 ANKRD46 ANKRD44 KANK1 TRANK1 ASB6 ASB11 PPP1R16B ANKRD52 | 3.45e-07 | 242 | 113 | 11 | 403 |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 4.69e-06 | 6 | 113 | 3 | 699 | |
| GeneFamily | DEAH-box helicases | 1.25e-04 | 16 | 113 | 3 | 500 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.67e-04 | 50 | 113 | 4 | 1293 | |
| GeneFamily | Ferlin family | 5.71e-04 | 6 | 113 | 2 | 828 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.35e-03 | 9 | 113 | 2 | 1234 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.35e-03 | 9 | 113 | 2 | 1230 | |
| GeneFamily | C-type lectin domain family | 3.16e-03 | 47 | 113 | 3 | 494 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-08 | 199 | 169 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 4.53e-07 | 180 | 169 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.67e-07 | 193 | 169 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.67e-07 | 193 | 169 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-07 | 195 | 169 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-07 | 198 | 169 | 8 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-07 | 198 | 169 | 8 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.66e-07 | 199 | 169 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-06 | 187 | 169 | 7 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 8.89e-06 | 192 | 169 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.19e-06 | 193 | 169 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 9.19e-06 | 193 | 169 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.51e-06 | 194 | 169 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 199 | 169 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-Proliferative_Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.53e-05 | 152 | 169 | 6 | e427758a6e39052616a0d8ecec0c1299e81d1d3c | |
| ToppCell | E16.5-samps-Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.93e-05 | 156 | 169 | 6 | c7c73cef5700b0ae75280e62c94728434c712537 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.26e-05 | 159 | 169 | 6 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.62e-05 | 162 | 169 | 6 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 162 | 169 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.62e-05 | 162 | 169 | 6 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.62e-05 | 162 | 169 | 6 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-05 | 166 | 169 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.44e-05 | 168 | 169 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.59e-05 | 169 | 169 | 6 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 5.22e-05 | 173 | 169 | 6 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.75e-05 | 176 | 169 | 6 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 176 | 169 | 6 | a3f27b5d7edf2d396c085efbe35305cfa0afa565 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 176 | 169 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.93e-05 | 177 | 169 | 6 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.12e-05 | 178 | 169 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.51e-05 | 180 | 169 | 6 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 181 | 169 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 6.71e-05 | 181 | 169 | 6 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 181 | 169 | 6 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 182 | 169 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-05 | 182 | 169 | 6 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.92e-05 | 182 | 169 | 6 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 183 | 169 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 183 | 169 | 6 | c9d9d7dd629ce6787502103b158a07e8684a66f8 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 7.13e-05 | 183 | 169 | 6 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 183 | 169 | 6 | c7ef8ee2b3fcfa69cea0fdcb2041674b832933db | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 183 | 169 | 6 | 92eee4bdd84965ae0bd1ed1c7f26a3b83ad0cdac | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 7.57e-05 | 185 | 169 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.80e-05 | 186 | 169 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-05 | 186 | 169 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 187 | 169 | 6 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 187 | 169 | 6 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 187 | 169 | 6 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | P07-Hematopoietic-Erythroid|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.41e-05 | 117 | 169 | 5 | 1820396bd590020a83fac3416d559e32f41eab61 | |
| ToppCell | P07-Hematopoietic-Erythroid-enucleate_erythrocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.41e-05 | 117 | 169 | 5 | 43c7257788fe3d53d663365d1754aee6ad88bbc5 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 8.52e-05 | 189 | 169 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.77e-05 | 190 | 169 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.02e-05 | 191 | 169 | 6 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | Ciliated-cil-3|World / Class top | 9.29e-05 | 192 | 169 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.55e-05 | 193 | 169 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-05 | 193 | 169 | 6 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-05 | 193 | 169 | 6 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 9.55e-05 | 193 | 169 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.83e-05 | 194 | 169 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 196 | 169 | 6 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 196 | 169 | 6 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 196 | 169 | 6 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 196 | 169 | 6 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 197 | 169 | 6 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 197 | 169 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-pDC|Influenza_Severe / Disease, condition lineage and cell class | 1.07e-04 | 197 | 169 | 6 | e8e6f71e6dc8a695e4321a18543c1df63dd62f3e | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 197 | 169 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 197 | 169 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 198 | 169 | 6 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 198 | 169 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 198 | 169 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 198 | 169 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.10e-04 | 198 | 169 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-early_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 198 | 169 | 6 | 8d900a17667a41bdfa683a34275fe4c059f6a8ef | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.13e-04 | 199 | 169 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.13e-04 | 199 | 169 | 6 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-04 | 199 | 169 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.13e-04 | 199 | 169 | 6 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-MAIT|ICU-SEP / Disease, condition lineage and cell class | 1.13e-04 | 199 | 169 | 6 | 2f10622319c6146dfed8cfe3844180c1e1d56e94 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 169 | 6 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 169 | 6 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 169 | 6 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 169 | 6 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 169 | 6 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 169 | 6 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 169 | 6 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| Disease | Jeune thoracic dystrophy | 1.87e-04 | 4 | 166 | 2 | cv:C0265275 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 3.11e-04 | 5 | 166 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | reaction time measurement | MYO1G GPR155 ATP13A1 PLA2G3 LRRC37A2 MCC DYSF ANKRD44 EFHD1 DHFR TSHZ1 CDC27 | 3.69e-04 | 658 | 166 | 12 | EFO_0008393 |
| Disease | Neoplasms, Therapy-Associated | 4.65e-04 | 6 | 166 | 2 | C0086696 | |
| Disease | Neoplasms, Second Primary | 4.65e-04 | 6 | 166 | 2 | C0085183 | |
| Disease | Treatment related secondary malignancy | 4.65e-04 | 6 | 166 | 2 | C0877578 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 6.49e-04 | 7 | 166 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 7.19e-04 | 261 | 166 | 7 | C0004352 | |
| Disease | urate measurement, bone density | SYNE1 MCC PKDCC CLASP2 RIPK4 DHX33 DNAH1 PTPRG MAP4K5 PPP1R16B DNAH9 | 7.99e-04 | 619 | 166 | 11 | EFO_0003923, EFO_0004531 |
| Disease | leptin measurement | 1.15e-03 | 81 | 166 | 4 | EFO_0005000 | |
| Disease | platelet component distribution width | MYO1G SCN11A SYNE1 RTTN PSMD2 SMOC2 ASAP1 TRANK1 BAZ2A RAPGEF3 GCC2 PPP1R16B | 1.22e-03 | 755 | 166 | 12 | EFO_0007984 |
| Disease | Jeune thoracic dystrophy | 1.67e-03 | 11 | 166 | 2 | C0265275 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.67e-03 | 11 | 166 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.83e-03 | 43 | 166 | 3 | EFO_0022290 | |
| Disease | Malignant neoplasm of salivary gland | 2.09e-03 | 45 | 166 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 2.36e-03 | 47 | 166 | 3 | C0036095 | |
| Disease | Adenoid Cystic Carcinoma | 2.49e-03 | 100 | 166 | 4 | C0010606 | |
| Disease | phospholipids in medium LDL measurement | 2.66e-03 | 49 | 166 | 3 | EFO_0022183 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.97e-03 | 105 | 166 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Hypertriglyceridemia | 3.15e-03 | 15 | 166 | 2 | C0020557 | |
| Disease | YKL40 measurement | 3.15e-03 | 15 | 166 | 2 | EFO_0004869 | |
| Disease | total lipids in LDL measurement | 3.16e-03 | 52 | 166 | 3 | EFO_0022308 | |
| Disease | Dupuytren Contracture | 3.29e-03 | 108 | 166 | 4 | EFO_0004229 | |
| Disease | osteosarcoma (is_implicated_in) | 3.58e-03 | 16 | 166 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.63e-03 | 111 | 166 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | asthma, response to diisocyanate | 3.70e-03 | 261 | 166 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | triacylglycerol 52:2 measurement | 3.70e-03 | 55 | 166 | 3 | EFO_0010414 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.90e-03 | 56 | 166 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 3.90e-03 | 56 | 166 | 3 | EFO_0022250 | |
| Disease | muscular dystrophy (is_implicated_in) | 4.05e-03 | 17 | 166 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Moyamoya Disease | 4.05e-03 | 17 | 166 | 2 | C0026654 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 4.10e-03 | 57 | 166 | 3 | EFO_0022284 | |
| Disease | migraine disorder | 4.21e-03 | 357 | 166 | 7 | MONDO_0005277 | |
| Disease | phospholipids in LDL measurement | 4.30e-03 | 58 | 166 | 3 | EFO_0022294 | |
| Disease | information processing speed, response to cranial radiation therapy | 4.30e-03 | 58 | 166 | 3 | EFO_0004363, EFO_0010950 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 4.51e-03 | 59 | 166 | 3 | EFO_0022289 | |
| Disease | Child Behaviour Checklist assessment | 4.54e-03 | 18 | 166 | 2 | EFO_0005661 | |
| Disease | immature platelet measurement | 4.65e-03 | 119 | 166 | 4 | EFO_0803541 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 4.68e-03 | 274 | 166 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 4.73e-03 | 60 | 166 | 3 | C4722327 | |
| Disease | colorectal cancer (is_implicated_in) | 4.93e-03 | 121 | 166 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | sphingomyelin measurement | 5.02e-03 | 278 | 166 | 6 | EFO_0010118 | |
| Disease | neck circumference | 5.05e-03 | 19 | 166 | 2 | EFO_0011043 | |
| Disease | toxic shock syndrome (is_marker_for) | 5.05e-03 | 19 | 166 | 2 | DOID:14115 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 5.59e-03 | 20 | 166 | 2 | DOID:783 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIHDALLEAILGKET | 1111 | P23470 | |
| VDLFGIADLAHLLLF | 951 | O60566 | |
| SKVLADVAIIFSGLH | 631 | Q9Y5B0 | |
| DLHISNKLFVLDAGA | 921 | P53355 | |
| LAALEKFEQLTLDGH | 296 | Q9BT22 | |
| LKDLEEHIISAGLAD | 311 | Q93034 | |
| AHFAGSLLLLVVDQK | 101 | Q86XM0 | |
| AKNLSHLDTVLGALD | 36 | Q9UNS2 | |
| LSGFHALRADLEKLT | 1491 | P0C0L5 | |
| LDHFSKSLFLDLVEL | 366 | O15254 | |
| KAAVLAFLVHELNGS | 971 | Q9UIF9 | |
| ALKHADVGVALLANA | 871 | Q9HD20 | |
| FALASHLIEAKLEGH | 506 | Q9NZN4 | |
| SVFLDKLTAGHLEEL | 1351 | Q7Z2Y8 | |
| TSLAEKLLFHGENIE | 146 | A0PJZ0 | |
| KGLLLIFVVDSADHS | 86 | Q6T311 | |
| GTLISKNFAALLEEH | 81 | Q9H4I9 | |
| GFALVLDAHENLLLA | 121 | Q9NUS5 | |
| LEFGAKAQLEVHLAS | 151 | Q8WXH4 | |
| VGSLAEKIQALHFSL | 351 | Q9NWX5 | |
| NEKVLGLLLAHSADV | 86 | Q8NB46 | |
| CQLLHKFGADLLATD | 61 | Q86W74 | |
| TLHTDILFGLIKDVA | 526 | O60231 | |
| LDQLKLAFTLDHETG | 551 | Q8IYB7 | |
| FADVLVHRLLAAALG | 706 | Q8IYB7 | |
| LHDVSDFLLEAAKLA | 246 | Q8N5B7 | |
| EEKGLISAFTIAHEL | 391 | P59510 | |
| RVELAAHKSLAGAEL | 336 | Q6ZRP7 | |
| IKDSLLDGHFVLATL | 251 | Q99638 | |
| IFSALSQLLEHGLDL | 336 | Q8TAE7 | |
| VAVEHALLALKFILA | 596 | Q9NW15 | |
| LTELHKDSFEGLLSL | 901 | O60309 | |
| QELHSLGAALAEKLD | 801 | A5PL33 | |
| ASEHLELIFGLDLKE | 156 | Q96LZ2 | |
| DTIDFHLLTALGKVS | 456 | Q8NCT3 | |
| LTELHKDSFEGLLSL | 901 | A6NM11 | |
| LTELHKDSFEGLLSL | 901 | A6NMS7 | |
| LSSHAAKLGAQLADL | 96 | Q9HA64 | |
| ITKKAFTGLDALEHL | 401 | Q6UXM1 | |
| EFRKHGIGSLLLESL | 106 | Q9H7X0 | |
| ISFGIFGLDKHLIIL | 706 | Q7Z3F1 | |
| IHFLDKELTGLNEAL | 111 | P04035 | |
| QLEVHAAAIKSLGEL | 146 | Q9UHD0 | |
| ATELDRHKILLHLGF | 156 | Q8N3F9 | |
| LSGLALDHKVTGDLF | 236 | O75387 | |
| ILDAFKASGDHNILI | 681 | O95786 | |
| LALAKGGLSDDHVLI | 351 | Q69YN2 | |
| LLIAAGQHFEDSKEL | 401 | O95382 | |
| LTIGADLHFAKGLRE | 456 | P55058 | |
| VADSGLTLKGFLFLH | 241 | Q8IXI2 | |
| LEILAALFAAAIHDV | 461 | P27815 | |
| LEILAALFASAIHDV | 416 | Q08493 | |
| DGIKLDLSHEFSLVA | 31 | Q96Q89 | |
| FAAISALKVGADLSH | 91 | Q8IW45 | |
| FLHLLTGNLALLADE | 461 | Q8WX92 | |
| SIALEAGHKDIAVLL | 1306 | Q14678 | |
| HLKEILLFVNAEAFS | 56 | Q9H1L0 | |
| VHLEKGDLSTALEVA | 831 | P42704 | |
| GLAHAIRLLLEFTDT | 16 | P21266 | |
| EDGTISFLDVIALKH | 316 | Q96EN8 | |
| ELAHLKSFVASLQLG | 1411 | Q92887 | |
| LDEIGHIKLTDFGLS | 206 | Q9UK32 | |
| LAAFKGHTECVEALI | 606 | Q8N8A2 | |
| KSIFLHHLEIELAAG | 916 | Q9UKX5 | |
| ELGTAVALIKTHDLD | 361 | Q9Y5G1 | |
| EFILLGLTDHAELKA | 11 | Q8NH18 | |
| GLTDHAELKAVLFVV | 16 | Q8NH18 | |
| GLDLTFIIHALLVKD | 536 | Q8IYI6 | |
| LALELHKTQGTLEGF | 1326 | O95613 | |
| LAAKEALGHLSLAEV | 5516 | Q5VST9 | |
| LVGSLEKNEFITLAH | 401 | P51003 | |
| DNFEEIVKLLLSHGA | 111 | Q96T49 | |
| LAKELLDLVASHFNL | 41 | Q9P2Q2 | |
| ARELLDLVASHFNLK | 81 | Q9Y2L6 | |
| ASLLNLFDKGILATH | 681 | Q9P2D7 | |
| GAKELHLFDIILTSV | 2541 | Q8NCM8 | |
| ALHLLLLFAAGAEKL | 16 | Q92896 | |
| KLLFGHSTEGDILEL | 161 | Q9UHY7 | |
| HSAALASLKGDIVEL | 21 | P23508 | |
| LAGIAAIKAHLDILV | 86 | P06340 | |
| ENDFLHSLLGKVIAS | 356 | Q92608 | |
| KVLIHGFTQSLLLDD | 691 | Q8WTW3 | |
| DHILETLSALAVDLG | 401 | Q9Y223 | |
| LISHLGELKLADFGL | 231 | Q96Q40 | |
| KFEALAAHDALVELS | 311 | P07954 | |
| IEFLSFLHLKEAGAL | 91 | P22466 | |
| GAHFLSRSLDDALKL | 86 | P00374 | |
| AASALGAAVRLHLEL | 121 | P23610 | |
| DHLILQASLKGELEA | 1241 | Q8IWJ2 | |
| KGAVDALAAALAHIS | 556 | Q9BQ39 | |
| AIAQLDLLGALEHKD | 471 | Q9H6R0 | |
| HNVIFTLDSLLKGDL | 141 | Q9ULH1 | |
| AARKATAAVIFLHGL | 16 | O75608 | |
| FLLIFHKAAAGELQE | 151 | Q9BUP0 | |
| ELKEAAGSLLHLAGI | 396 | P32314 | |
| TGALHLARLAKDSAA | 106 | A6NNB3 | |
| GAHFLARSLDDALKL | 86 | Q86XF0 | |
| DHLLGVSDSGKIVFL | 31 | Q9Y2T3 | |
| SVDKLGLAEDLVLHV | 66 | E5RQL4 | |
| LHVVEGLLKTALDFH | 446 | Q9NYC9 | |
| EHAFKLLDIAGNLLE | 541 | Q9NYC9 | |
| AAHIAVLDSELFLEK | 1381 | Q49AJ0 | |
| LGLLHFVKDFSKLLA | 271 | Q96CH1 | |
| SGLAALAKVLLSLEH | 336 | P49327 | |
| LLGHEFVLTEELDKA | 606 | P30260 | |
| ITEAALALKLGHSEL | 751 | O75923 | |
| GHFTSAEDLNLLIAK | 21 | Q16531 | |
| TFLKGLGAVILVHAE | 186 | Q14194 | |
| LSGFHALRADLEKLT | 1491 | P0C0L4 | |
| GNHIRKALLDIADLF | 751 | Q92523 | |
| HLGINDKDLAEFVIS | 41 | Q14562 | |
| ILLTDHGDVKLADFG | 146 | Q9Y4K4 | |
| FELTGKVEAELHLLT | 1901 | Q9HC10 | |
| GLVEHHLFALATLKD | 606 | Q12923 | |
| ILKSLGELGLEHFQA | 216 | Q9NZT2 | |
| ELEKGSLFLVDHGIL | 281 | O15296 | |
| LKLLAFHLTSEEGAD | 776 | Q86VV8 | |
| QFLSVLLTEEAKGHL | 1796 | Q86VV8 | |
| LADLHGTVAFKDFIL | 346 | Q6ZV65 | |
| ILEGHLGVTKELLAF | 1426 | Q93008 | |
| LLFDQLHEGAKALDV | 71 | P22061 | |
| ALELGSTEVLLDHLK | 126 | Q9UM63 | |
| DLFGDLLLKQALESH | 426 | Q15147 | |
| AAVALKAVDFSGHDL | 161 | Q504Y2 | |
| DESILISLSFHLGKL | 306 | Q6NUP7 | |
| IHAVANIGTALKFLE | 86 | Q8NF91 | |
| VKDSLFFLHELGEQL | 7296 | Q8NF91 | |
| AEFVDIDGKSHLILS | 376 | Q8N0V4 | |
| ASVALGLDLRELHKA | 731 | Q5TCX8 | |
| LAATLVLHLALADGA | 56 | Q9NPC1 | |
| KLLSAGIFSDIHLLA | 196 | A6NDU8 | |
| NVLLSEHGEVKLADF | 161 | Q9Y6E0 | |
| DGGLFLLADVSHKVI | 371 | Q8TC59 | |
| HLGKGEAIEAILAAL | 566 | Q13200 | |
| LLSALGLALADVVHE | 516 | O14841 | |
| LTAAHALAVDAKNLL | 1021 | Q05397 | |
| FGSTHAEALLKAAIE | 2086 | Q8NFP9 | |
| LQSHAKAIVLVLFGA | 681 | Q9Y6C5 | |
| RAISSLDLLGDFKHA | 1016 | Q9ULL8 | |
| ELLKNLVLTGFSHID | 31 | Q9UBT2 | |
| LVLTGFSHIDLIDLD | 36 | Q9UBT2 | |
| VLDAHFLVLASDLGK | 131 | Q9NXX6 | |
| AALFEGKVQLHLIES | 441 | Q8NEZ3 | |
| KISDLGVAEALHPFA | 191 | Q15831 | |
| VASEALAELLHGALL | 46 | Q6UXD5 | |
| GHLAAVEVLLKLGAD | 236 | A8MXQ7 | |
| VDNDFHIKIADLGLA | 146 | Q13546 | |
| SFLAKDAQGLALIHA | 46 | Q9NZ20 | |
| LALDSGASLLHLAVE | 481 | P57078 | |
| HFLILLFSKDEDISL | 271 | Q08945 | |
| GALNRKESFLLLSLH | 41 | A5D8T8 | |
| GALNRKESFLLLSLH | 41 | Q6UXF7 | |
| GALNRKESFLLLSLH | 41 | Q8NCF0 | |
| FQHLRLLDGALKLSA | 131 | O75122 | |
| AGKIDLLRDSHIFQL | 1221 | Q63HN8 | |
| FLLLGVKVHSLSSEE | 191 | Q8TCV5 | |
| ELAAVLLFEPHSKAG | 256 | O95398 | |
| SVIILGLAFGHLESK | 131 | Q86W33 | |
| GLHDIKNAELALFEL | 191 | Q8NBP0 | |
| HLLAADVLLGEDASL | 2016 | Q8IZQ1 | |
| DEISILLLGVAHFKG | 201 | P36955 | |
| GAKKHEFLTSVLDAL | 306 | Q9H3U7 | |
| TLTRLAAILAKHFAD | 896 | Q5XPI4 | |
| AAILAKHFADARIVG | 901 | Q5XPI4 | |
| QISLLIGKGLHEFDS | 116 | O00329 | |
| GEKTVAALALLFAIH | 1131 | Q14683 | |
| LKVSFASLDLVLHLE | 1531 | Q709C8 | |
| LLSAEFGKHLLEVED | 551 | P11277 | |
| LTGFHLLDGKTHLFI | 266 | Q6ZUG5 | |
| LLDGKTHLFILEGLA | 271 | Q6ZUG5 | |
| KDDFVDLLLQHIGTS | 146 | Q9UPN7 | |
| FRSLGELDLHKLAHT | 3096 | Q96JG9 | |
| ILLSSGALIFEDVHL | 1066 | Q9UI33 | |
| EIKADIGFSFLSHLL | 511 | O15050 | |
| LALLLHESLDSGEKF | 301 | Q8NA31 | |
| HVLEIAALKGSASEA | 856 | O75385 | |
| ISHLETHLGFSLKDL | 986 | Q6ZSZ6 | |
| LFGQHLATEVIFKAL | 76 | O14657 | |
| SVLLAFSVLGELHSK | 226 | O43264 | |
| IHLAGKLLASDAEAL | 481 | Q96S06 | |
| NHLLGSDKAAVSALL | 661 | B0I1T2 |